Carib Scope

分类： health

  • Guyana offers Caribbean training, long-distance robotic telesurgery

    Guyana offers Caribbean training, long-distance robotic telesurgery

    In a landmark breakthrough that redefines the boundaries of modern medical innovation, the South American nation of Guyana has successfully completed the world’s longest-distance robotic-assisted telesurgery, marking a new era in accessible, high-precision healthcare across the Caribbean region. The unprecedented procedure, performed on May 26, 2026, saw internationally renowned cardiac surgeon Dr. Sudhir Srivastava, founder of India-based SS Innovations, conduct a Coronary Artery Bypass Graft (CABG) on a patient located 20,000 kilometers away in India, operating from a control room at Georgetown Public Hospital (GPHC) in Guyana.

    President Irfaan Ali announced the historic achievement at an official press briefing Tuesday night, alongside Health Minister Dr. Frank Anthony and a multi-national team of medical specialists. He emphasized that Guyana’s new technological leap positions the country to serve as a regional hub for robotic surgery, extending access to this cutting-edge care to all member states of the Caribbean Community (CARICOM).

    “What patients can access in the most advanced medical facilities in India will be available right here in Guyana for the entire region in the coming weeks,” President Ali stated. “Our plan builds a central robotics, surgery and care hub based in Guyana, with outposts across the Caribbean, and we will provide full training for medical teams from every CARICOM nation.” To support this initiative, Guyana has purchased a complete robotic surgery training module and finalized an agreement with SS Mantra, the Indian developer of the surgical system used in the procedure, to establish an accredited international training center on its soil. Previously, all of Guyana’s surgical teams traveled to India to complete certification on the system.

    Health Minister Dr. Frank Anthony confirmed the training program will receive formal accreditation and will be integrated into post-graduate fellowship training offered through the University of Guyana and the Ministry of Health. The milestone telesurgery procedure beat the previous world record for the longest-distance robotic surgery, also set by SS Mantra for a procedure between Australia and India. Multiple layers of internet redundancy were built into the operation, with an on-site Indian surgical team on standby to take over if connectivity issues arose, and the procedure was completed without complications.

    Alongside the historic telesurgery milestone, GPHC also announced a second first for the English-speaking Caribbean: the first fully local robotic surgery, a successful inguinal hernia repair performed by Guyanese surgeon Dr. Hemraj Ramcharran, with support from Dr. Bibi Hussain and Dr. Jagnanand Ramnarine. Ramcharran is now the first Caribbean surgeon to complete a robotic procedure within the region.

    Medical experts outlined the transformative benefits of the latest-generation SSI Mantra robotic system, noting it delivers high-resolution 3D magnified views of surgical sites and allows for precision control of tissue manipulation within fractions of a millimeter — a level of accuracy impossible to achieve with traditional open surgery. Unlike conventional open-heart surgery that requires splitting the sternum (breastbone), robotic-assisted procedures use small incisions between ribs to access the surgical site, drastically reducing patient recovery time, blood loss, post-operative infection risk, and complications such as deep vein thrombosis.

    Cost is another major advantage: traditional open-heart surgery typically costs between $6,000 and $12,000 U.S. dollars, including a minimum seven-day post-operative hospital stay, while robotic-assisted surgery cuts that cost by 50%. Critically, GPHC announced it will offer all robotic-assisted procedures to patients completely free of charge.

    To advance the expansion of robotic surgery in Guyana and the region, President Ali has established a new Robotics Advisory Committee, co-chaired by prominent Guyanese cardiologist Dr. Mahendra Carpen, with members including Dr. Anthony, Dr. Riyad Gafoor, Satindra Prasad, and Steve Carryl. Officials are already working to address remaining gaps in local expertise, including training for a perfusionist — a specialized clinician who operates the heart-lung machine used during cardiac surgery — with SS Innovations assisting with placement for international training.

    Barbados Prime Minister Mia Mottley, who delivered remarks at the briefing, welcomed Guyana’s regional offer, noting the new hub will help reduce the growing backlog of delayed surgeries across CARICOM member states. GPHC officials called the dual achievements a groundbreaking milestone in global healthcare, positioning Guyana as a leader in medical innovation and expanding access to life-saving care for underserved populations across the Caribbean.

  • Air Peace Says It Does Not Fly to Ebola-Affected Countries Amid Caribbean Health Concerns

    Air Peace Says It Does Not Fly to Ebola-Affected Countries Amid Caribbean Health Concerns

    As global health authorities ramp up monitoring of a renewed Ebola outbreak that has sparked alarm across the Caribbean region, Nigerian commercial airline Air Peace has moved quickly to reassure the public and travelers that it currently maintains no flight routes to any countries grappling with active Ebola transmission. This public clarification comes at a time when international health organizations have issued updated alerts, urging cross-border travel and transportation operators to strengthen screening protocols and communicate transparently about their route networks to prevent the accidental importation of the virus into new regions.

    Air Peace’s statement addresses growing public anxiety that has emerged in recent weeks, as scattered Ebola cases in several West and Central African countries have rippled out to stoke concerns among Caribbean communities and travel industry stakeholders, who still remember the devastating 2014-2016 Ebola epidemic that claimed thousands of lives and disrupted global travel across the African continent and beyond. The carrier emphasized that it has proactively reviewed its entire international route map to confirm that no scheduled or charter services connect its operational network to Ebola-affected jurisdictions, and it noted that it is working closely with global and local public health agencies to maintain strict health screening protocols for all incoming and outgoing passengers, even for routes that do not pass through outbreak zones.

    Travel industry analysts note that this kind of proactive communication is critical for maintaining public confidence in air travel, particularly amid emerging infectious disease outbreaks, where misinformation can spread quickly and cause unnecessary disruption to airline operations and regional tourism. Caribbean public health officials have already stepped up entry screening at major international airports across the region, and have urged all air carriers to provide clear, up-to-date information about their route networks to help authorities coordinate effective outbreak response measures.

  • Wins, Gaps and the Road Ahead for Healthy Food Policy in the Caribbean

    Wins, Gaps and the Road Ahead for Healthy Food Policy in the Caribbean

    Across the Caribbean region, efforts to build more equitable, nutrition-focused food systems have yielded measurable progress in recent years, yet deep-rooted gaps continue to undermine public health outcomes and leave vulnerable communities underserved. For decades, Caribbean nations have grappled with a dual burden of malnutrition: widespread diet-related noncommunicable diseases (NCDs) such as diabetes, hypertension, and obesity, coexisting with persistent food insecurity in low-income coastal and rural communities. These challenges have spurred regional bodies and national governments to roll out targeted healthy food policies aimed at reshaping food environments and improving access to nutrient-dense, local produce.

    Notable policy wins have already transformed regional food landscapes in meaningful ways. Several Caribbean states have implemented mandatory front-of-package warning labels for processed foods high in sugar, salt, and saturated fat, giving consumers clear, accessible information to make informed purchasing decisions. Some governments have also introduced fiscal measures, including taxes on sugary beverages and processed snacks, while offering subsidies to small-scale local farmers growing fruits, vegetables, and legumes. These initiatives have cut consumption of unhealthy products in multiple markets, and boosted demand for locally grown nutrient-dense foods, supporting both public health and smallholder livelihoods. Regional collaborative bodies, such as the Caribbean Public Health Agency (CARPHA), have also streamlined knowledge sharing between nations, helping smaller states adopt evidence-based policies without starting from scratch.

    Despite these advances, significant gaps remain that block widespread, equitable impact. Many policies suffer from weak enforcement, particularly in informal markets where unlabeled processed food is widely sold, and tax loopholes allow vendors to avoid price adjustments that would discourage unhealthy purchases. Infrastructure barriers also persist: inadequate cold storage and transportation networks leave small farmers unable to get fresh produce to urban markets at affordable prices, eroding the impact of agricultural subsidies. Additionally, policy design often fails to center the needs of marginalized groups, including Indigenous communities, low-income households, and remote island populations, who face the highest rates of diet-related illness but are rarely included in the policy development process. The powerful influence of transnational processed food corporations, which invest heavily in marketing unhealthy products across the region, also creates political and economic headwinds that slow policy progress.

    Looking ahead, stakeholders across the region agree that closing these gaps will require coordinated, multi-sector action that prioritizes equity and community leadership. Experts argue that strengthening enforcement capacity, investing in food distribution infrastructure, and increasing community participation in policy design will be critical to expanding the impact of existing initiatives. Moving forward, regional cooperation will also be key: pooling resources for research, supporting small island states with limited administrative capacity, and advocating collectively against industry interference can help Caribbean nations build food systems that deliver better health for all residents. While the road ahead includes significant challenges, the early policy wins across the region provide a strong foundation for future progress.

  • HEBERSaVax: The story of a Cuban product, unique in the world, with great potential in the fight against cancer

    HEBERSaVax: The story of a Cuban product, unique in the world, with great potential in the fight against cancer

    On the afternoon of May 27, 2026, Cuban President Miguel Díaz-Canel Bermúdez, who also serves as First Secretary of the Central Committee of the Communist Party of Cuba, chaired a regular meeting of health sector experts and scientists at Havana’s Palace of the Revolution. The gathering’s most anticipated highlight was an update on HEBERSaVax, a groundbreaking Cuban-developed therapeutic vaccine candidate for treating multiple types of malignant tumors, a development that has already sparked early optimism for global cancer care.

    During the session, Díaz-Canel extended formal congratulations to HEBERSaVax lead scientist Yanelys Morera Díaz, a full member of the Cuban Academy of Sciences, and her entire research team. Following the conclusion of the meeting, Morera spoke to state press about the vaccine’s mechanism and developmental progress, outlining how the innovative candidate works to stop cancer progression.

    Morera explained that HEBERSaVax functions as a form of active immunotherapy, targeting two critical aspects of tumor growth. First, it prompts the body to produce specific antibodies that block the blood supply tumors need to access nutrients and oxygen for expansion. Second, it reactivates the patient’s own immune system to recognize and attack cancer cells, creating a multi-functional approach to treatment.

    After completing all preclinical testing, including early trials in laboratory animal models, the candidate has advanced to Phase II clinical trials focused on specific tumor types. Morera emphasized that early safety data shows the therapy has a strong tolerability profile, with only mild, manageable adverse effects. This low toxicity profile allows HEBERSaVax to be combined with conventional cancer treatments without increasing harmful side effects, opening the door for broad clinical applications. While the candidate remains in active research, Morera noted that many trial participants have already reported meaningful improvements to their quality of life, with some patients with advanced-stage cancer achieving complete responses to treatment. Moving forward, the research team must continue compiling clinical evidence to meet Cuba’s rigorous national regulatory standards before advancing to later trial phases. Morera expressed confidence that the candidate will successfully complete all required testing and eventually become a core tool in global cancer treatment, with long-term plans to integrate the therapy into primary care settings.

    Other members of the research team echoed Morera’s cautious optimism. Julio César Hernández Perera, an internal medicine specialist, full member of the Cuban Academy of Sciences and clinical researcher on the project, described HEBERSaVax as a one-of-a-kind achievement of Cuba’s robust biotechnology sector, built on decades of targeted research. He noted that the candidate could eventually be used to treat a wide range of solid tumors, which often rely on the specific protein targeted by the vaccine to grow and spread. Its low toxicity makes it a viable option even for patients living with multiple chronic conditions, a major advantage over many conventional aggressive treatments. Like Morera, Hernández Perera called for continued research investment, but stressed that the candidate already opens new, previously unreachable frontiers in cancer care.

    Young clinical researcher Adriana Felinciano Pozo, another internal medicine specialist on the team, added that HEBERSaVax’s simple subcutaneous administration makes it easy to deploy in a wide range of care settings. Early trial results across multiple hard-to-treat solid tumor types — including colorectal cancer, hepatocellular carcinoma, ovarian cancer, and kidney cancer, all in advanced patient populations — have delivered consistent positive responses. Felinciano Pozo emphasized that cancer remains one of the leading global causes of death and long-term disability, making accessible, low-toxicity new therapies a critical global public health need.

    The report frames HEBERSaVax’s development as a testament to Cuba’s enduring commitment to protecting the fundamental human right to health and life, even amid long-standing external economic pressure that has strained the country’s resources. The work of the HEBERSaVax research team exemplifies how Cuban biotechnology continues to advance life-saving innovation despite significant challenges.

  • Fatty liver disease may be on rise as Bajans ‘over-drink’ – doc

    Fatty liver disease may be on rise as Bajans ‘over-drink’ – doc

    A general practitioner based in Barbados has sounded the alarm over a potential growing prevalence of steatotic liver disease, more commonly known as fatty liver disease, driven by widespread excessive alcohol consumption across the island nation. Dr. Thalayah Butcher-Medford shared her public health concerns during a Sunday community health fair hosted by the Blessed Hope Seventh-day Adventist church at Husbands Gardens, St. James, where she delivered an educational presentation on the silent, life-threatening condition.

    In her address to attendees, Dr. Butcher-Medford emphasized how the public frequently underestimates the long-term damage caused by regular alcohol overconsumption, alongside excessive sugar intake that contributes to metabolic conditions like diabetes. “The liver acts as the body’s primary filter, processing every substance that enters your bloodstream. Even if heavy drinking or poor diet causes no immediate discomfort, that accumulated damage will catch up to you as you age,” she explained.

    One of the most dangerous characteristics of early-stage fatty liver disease, the practitioner noted, is its lack of obvious, recognizable symptoms. Most people living with the condition remain unaware of their diagnosis until damage progresses to advanced stages, when mild, easily overlooked signs begin to appear. “Early on, there are almost no red flags,” Dr. Butcher-Medford said. “The only reliable way to catch the disease early is through routine preventive check-ups with a healthcare provider, who can order blood work to check for abnormal liver enzyme levels that signal potential damage.”

    This absence of early warning signs also complicates public health efforts to track which age groups face the greatest risk, as diagnoses most often come after the condition has already advanced. When symptoms do emerge, they are frequently dismissed as common minor ailments: persistent fatigue, abdominal bloating, and a protruding abdomen that many people simply write off as a “beer belly” or the result of work-related stress, rather than connecting them to a serious liver condition.

    Despite the potentially fatal outcomes of advanced fatty liver disease, Dr. Butcher-Medford stressed that the first three of the condition’s four stages can be fully reversed through intentional lifestyle modification. Key changes include adopting a nutrient-dense, low-sugar diet, increasing regular physical activity, and achieving sustainable weight loss. For people who drink heavily, cutting out alcohol entirely can start reversing early liver damage in as little as two to four weeks, she added. Only end-stage (stage 4) disease is irreversible, as at that point the liver loses its natural ability to regenerate, and patients require a liver transplant to survive.

    Advanced fatty liver disease carries two major life-threatening complications: cirrhosis, the permanent scarring that marks end-stage liver damage, and hepatocellular carcinoma, the most common form of liver cancer. While Dr. Butcher-Medford acknowledged that donor organs for transplant remain in short supply, she highlighted the unique resilience of the liver that makes transplants more feasible than many people realize. Because the liver can regenerate from partial tissue, a living donor who is a genetic match can donate a portion of their healthy liver, and both the donor’s remaining tissue and the transplanted portion will grow into fully functional, complete organs, often resulting in strong positive outcomes for recipients.

    Sunday’s health fair was part of the Blessed Hope Seventh-day Adventist church’s ongoing community outreach initiative, which provides local residents with free preventive health screenings, accessible health education, and wellness activities to promote long-term healthy habits. During the event, City Central SDA Pastor Dillon Basil joined attendees in getting a free blood pressure check, modeling proactive health care for the community.

  • UN says Ebola response in DR Congo faces challenges amid rising suspected cases

    UN says Ebola response in DR Congo faces challenges amid rising suspected cases

    The Democratic Republic of the Congo (DRC) is grappling with an accelerating Ebola outbreak that has sent suspected case and death counts climbing, prompting global health bodies and humanitarian networks to ramp up emergency interventions on the ground. Latest figures compiled by the World Health Organization (WHO) put the total number of suspected infections above 900, with roughly 220 people already suspected to have died from the virus, underscoring the rapid spread of the disease across affected regions.

    As global response efforts intensify, WHO Director-General Tedros Adhanom Ghebreyesus has announced plans to travel to the DRC to personally oversee and coordinate the outbreak response, according to a spokesperson for the United Nations Secretary-General. In a recent public update shared via social media, Tedros outlined that the WHO and 55 partner humanitarian organizations are already embedded in impacted communities, delivering not just Ebola-specific care but also critical basic health services, including life-saving treatment for acute malnutrition that disproportionately endangers local children and vulnerable groups.

    WHO technical and operational teams are working hand-in-hand with DRC national health authorities across nearly every pillar of outbreak control. Their work spans critical activities ranging from tracking close contacts of confirmed cases to managing active infections, upgrading infection prevention protocols in healthcare facilities, strengthening local laboratory capacity to process test results quickly, running dedicated Ebola treatment centers, engaging local community leaders to build trust, and communicating clear public health guidance to at-risk populations.

    Despite this coordinated push, major barriers continue to hinder the response. The UN has issued a stark warning that persistent insecurity and active violence in some of the most heavily affected hard-to-reach areas have thrown major logistical and safety challenges in the path of response teams, severely limiting their ability to reach isolated, vulnerable communities that need care the most.

    Working in close partnership with the DRC national government, the UN and its humanitarian allies are moving forward with plans to expand emergency operations, while also working to address the broader long-standing humanitarian and healthcare gaps that leave communities more vulnerable to Ebola spread. The UN spokesperson emphasized that two critical needs remain unmet: urgent, sustained funding to scale up operations, and guaranteed safe access for response teams. These resources are essential not only to protect frontline responders from infection, but to ensure they can deliver comprehensive care and full life-saving aid packages to every community impacted by the outbreak.

  • Ministry of Health Advises Public of Contained Chickenpox Cluster at Clarevue Psychiatric Hospital

    Ministry of Health Advises Public of Contained Chickenpox Cluster at Clarevue Psychiatric Hospital

    Antigua and Barbuda’s Ministry of Health, Wellness, Environment and Civil Service Affairs has issued a public advisory confirming a small cluster of varicella, more widely known as chickenpox, cases within two male-only wards at the Clarevue Psychiatric Hospital. As of the latest update, the outbreak has not spread beyond the two affected wards, and targeted public health interventions have already been rolled out to contain transmission and safeguard the health of both patients and hospital staff. The ministry emphasized that its standardized infection prevention and control protocols were activated immediately after the initial cases were detected.

    The full suite of response measures includes expanded active surveillance across the hospital facility, mandatory quarantine and isolation for exposed and confirmed cases, intensified cleaning and disinfection protocols for all high-touch environmental surfaces, limitations on non-essential movement through the affected wards, regular health monitoring for all individuals who have had close contact with infected patients, and ongoing clinical check-ins for all potentially affected staff and patients. Public health officials are working hand-in-hand with the hospital’s administration and on-site clinical teams to track the development of the outbreak closely, and to date, there is no evidence that the virus has spread to other parts of the facility or the broader community.

    To help the public understand the risks, the ministry has also shared key educational information about varicella. The illness is a highly contagious viral infection caused by the varicella-zoster virus, and common presenting symptoms include elevated body temperature, general fatigue, and an itchy blister-shaped rash across the skin. The virus spreads most often through respiratory droplets that enter the air when an infected person coughs or sneezes, or through direct physical contact with fluid from an infected person’s skin blisters. In rare cases, susceptible people can also contract varicella after exposure to someone with herpes zoster (commonly called shingles), which develops when the latent varicella-zoster virus reactivates in a person who previously had chickenpox.

    Small, localized clusters of varicella are not unusual, especially in closed congregate settings like psychiatric hospitals, where consistent close contact between people creates ideal conditions for the virus to spread. For most people, particularly healthy children, the illness runs a mild course and rarely causes serious long-term complications. Even so, public health officials stress that proactive prevention remains critical to protecting vulnerable populations.

    The ministry reminded the public that varicella vaccination continues to be one of the most effective tools available to prevent infection and reduce the severity of symptoms if infection does occur. The vaccine is accessible to both children and adults at all public health clinics across Antigua and Barbuda. Officials are urging parents and guardians to confirm that their children have received all required doses of the vaccine in line with the country’s national immunization schedule. Any person who is unsure about their own vaccination history is advised to reach out to their primary healthcare provider or the closest public health center for guidance.

    In addition to vaccination, the ministry is encouraging all residents to maintain routine infection prevention habits that reduce the spread of all contagious respiratory and viral illnesses. These core habits include washing hands frequently with soap and clean running water, covering the mouth and nose when coughing or sneezing to contain respiratory droplets, keeping infected people separated from public spaces and group settings until all skin blisters have crusted over completely, and contacting a healthcare provider promptly if a person develops symptoms that match a varicella infection.

    People who develop fever and a rash are specifically advised to avoid unnecessary close contact with groups that face a higher risk of severe complications, including older adults, pregnant people, newborn infants, and individuals with compromised immune systems. The ministry says it will continue maintaining active, round-the-clock surveillance of the outbreak, and will release additional public updates if any new developments that impact public health emerge.

  • CARPHA expands Caribbean early warning systems for vector-borne diseases

    CARPHA expands Caribbean early warning systems for vector-borne diseases

    The Caribbean Public Health Agency (CARPHA) is pushing forward landmark efforts to boost the region’s capacity to detect and respond to vector-borne diseases, rolling out expanded regional surveillance networks and cutting-edge monitoring technologies through a collaborative multi-country workshop held recently in Guyana.

    Held from April 27 to 28, 2026 at the Pegasus Hotel Exhibition Centre in Georgetown, the Regional Multisectoral Workshop, officially titled “Advancing Regional Vector-Borne Disease Surveillance through Technology and Harmonisation,” marks the latest milestone in a multi-phase regional public health initiative funded entirely through CARPHA’s Pandemic Fund Project. The convening gathered 28 key stakeholders, including senior epidemiology and vector control officials from 12 CARPHA member states, leadership from the Caribbean Vector-Borne Disease Network Steering Committee, and CARPHA’s in-house technical public health experts.

    This Georgetown gathering builds on two prior successful regional workshops held in Barbados (August 2025) and Trinidad and Tobago (December 2025), where participants focused on foundational topics including Integrated Vector Management, insecticide resistance testing, and the application of Geographic Information Systems (GIS) to Caribbean pandemic preparedness. Unlike earlier sessions that laid operational groundwork, the 2026 workshop centered on streamlining cross-border collaboration: participants worked to standardize regional disease datasets, validate unified early warning indicators, and integrate modern digital tools to enable faster, evidence-based decision-making across three core areas: epidemiological tracking, climate monitoring, and vector population surveillance.

    Lisa Indar, a senior CARPHA official, emphasized the ongoing urgency of the effort in her remarks, noting that vector-borne illnesses remain a persistent, major strain on Caribbean health systems and local communities. “As vector-borne diseases continue to pose a significant threat to Caribbean health systems and communities, CARPHA is working with Member States to strengthen the systems needed to detect risks earlier and respond more effectively,” Indar explained. “Through CARPHA’s Pandemic Fund Project, we are advancing integrated early warning systems, building technical capacity, and supporting the use of data and new technologies to guide timely public health action across the Region.”

    Horace Cox, CARPHA’s Director of Surveillance, Disease Prevention and Control, echoed this focus, noting that robust, standardized surveillance forms the backbone of any effective public health preparedness framework. “Effective surveillance is at the centre of public health preparedness. By strengthening the way countries collect, analyse, and share vector-borne disease data, we are improving the Caribbean’s ability to detect threats earlier and coordinate timely responses across the region,” Cox said.

    Roshan Parasram, another leading public health figure involved in the initiative, highlighted why modern, structured vector control systems are non-negotiable for Caribbean public health safety. “We are here because the Caribbean deserves a public health system that can see threats coming and act before they become crises,” Parasram stated. “We have built our approach on three pillars: Integrated Vector Management, Insecticide Resistance Testing, and Geographic Information Systems. These are not buzzwords. They are the operational backbone of a modern vector control system.”

    Brian Armour, who leads work on regional early warning infrastructure for CARPHA, further outlined the value of integrating vector surveillance into broader regional public health systems. “Our Regional Integrated Early Warning and Response System (RIEWSS) is about connecting data, systems, and people so that public health threats can be identified and acted upon more quickly,” Armour explained. “The integration of vector-borne disease surveillance into this broader early warning framework is an important step toward a more coordinated, data-driven approach to pandemic preparedness and response in the Caribbean.”

    Over the course of the two-day workshop, participants conducted in-depth reviews of proposed regional early warning indicators and evaluated methodologies to unify data collection and reporting across epidemiology, entomology, climate science, and geographic information systems. Technical breakout sessions explored the practical application of a range of innovative tools, including DHIS2 digital workflows, insecticide resistance analytics platforms, satellite remote sensing technology, artificial intelligence-powered risk mapping, and social listening tools designed to improve situational awareness and cut response times for public health agencies.

    Among the tools highlighted, DHIS2 — an open-source digital health information management platform — was singled out as a core enabling technology for the region’s new surveillance framework. The platform is designed to streamline the collection, analysis, and visualisation of public health data, enabling faster detection and response to emerging disease outbreaks.

    In addition to digital technology, participants also discussed new vector control innovations, including spatial repellents and emanator products engineered for use in the Caribbean’s densely populated urban centers. The workshop also included working sessions to review plans for formalizing the governance structure of the Caribbean Vector-Borne Disease Network Steering Committee and aligning stakeholders on the body’s upcoming work agenda.

    A key outcome of the convening was the opportunity for individual member states to assess which technologies and interventions best fit their unique national epidemiological contexts, while also mapping out the infrastructure, cross-border partnerships, and workforce training required to roll out new systems locally. CARPHA officials noted that the discussions and agreements reached at the workshop are expected to improve the consistency and timeliness of regional disease data reporting, strengthen cross-border coordination, and enable more targeted, effective vector control measures across the entire Caribbean region.

  • The Bahamas issues travel ban amid Ebola outbreak

    The Bahamas issues travel ban amid Ebola outbreak

    The Caribbean nation of The Bahamas has become the latest country to implement travel restrictions targeting three African nations grappling with a regional Ebola outbreak, barring all incoming travelers from the Democratic Republic of Congo, Uganda, and South Sudan.

    The temporary entry prohibition was announced publicly in an official press statement released by the country’s Davis administration this week, confirming that the policy was drafted in direct response to formal guidance issued by The Bahamas’ Ministry of Health and Wellness. The restrictive measure went into effect immediately upon announcement, with an initial 30-day validity period that will be reassessed by public health officials at the end of that window to determine whether extension or adjustment is needed.

    In the official statement, the administration emphasized that the ban was enacted as a proactive precautionary public health step, rooted in the government’s core obligation to safeguard the health of domestic residents, visiting tourists, and the broader national community. “The Ministry of Health and Wellness will continue to monitor developments of the African outbreak closely and will provide updated guidance to the government as shifting circumstances demand,” the statement noted. It added that the country’s Department of Immigration, working in tandem with national border control agencies and public health institutions, will roll out mandatory entry screening protocols at all of The Bahamas’ ports of entry to enforce the ban.

    Alongside the new entry ban, The Bahamas’ Ministry of Foreign Affairs has issued a formal travel advisory urging all Bahamian citizens to cancel all non-essential travel to the three restricted countries. The advisory also urges Bahamians to exercise heightened caution when planning travel to eight additional African nations: Kenya, Tanzania, Rwanda, Burundi, Angola, the Central African Republic, Ethiopia, and Zambia, all of which neighbor current outbreak zones.

    The government’s policy update comes as multiple regions across Central Africa are fighting a growing Ebola outbreak that has already resulted in hundreds of confirmed infections and deaths. The announcement also follows closely on the heels of a recent public health scare at one of the country’s major international airports, which unfolded after two foreign travelers arrived in The Bahamas on a British Airways flight originating from London’s Heathrow Airport this past Friday.

    The two passengers, one a citizen of the United Kingdom and the other a French national, had completed a three-week stay in the Democratic Republic of Congo before traveling onward to Ethiopia, and eventually to New Providence, The Bahamas’ most populous island. During routine entry health screening at Lynden Pindling International Airport, both men were found to have low-grade fevers, prompting health officials to immediately isolate them on-site before transferring them to the Princess Margaret Hospital for further monitoring and testing.

    As of the latest official update from Health Minister Dr. Michael Darville, the two individuals remain in isolation and are reported to be in stable, good condition. No additional Ebola-specific symptoms have been detected in either patient to date. “All required diagnostic testing is currently underway, and we will issue a public statement to media outlets as soon as the process is complete,” Darville said.

    Ebola is a rare, frequently severe and often fatal infectious disease caused by a group of viruses in the Orthoebolavirus genus. Early symptoms of infection typically include fever, intense headache, muscle and joint pain, fatigue, sore throat, and general weakness. In severe cases that progress, the disease advances to cause vomiting, diarrhea, and severe abdominal pain. To date, the Bahamas has not recorded any confirmed domestically detected cases of Ebola.

  • Sleep: The root of Grenada’s chronic disease crisis

    Sleep: The root of Grenada’s chronic disease crisis

    The Caribbean island nation of Grenada is facing a growing public health emergency of non-communicable diseases (NCDs), and a critical contributing factor has long flown under the radar of clinical care and public health planning: undiagnosed obstructive sleep apnea (OSA).

    For anyone walking through a local health center in Grenada, the prevalence of two of the most common NCDs — hypertension and type 2 diabetes — is immediately apparent. At Grenada General Hospital, the devastating long-term outcomes of uncontrolled conditions are on full display: patients recovering from strokes, living with heart disease, or undergoing dialysis to treat kidney failure. What makes these outcomes particularly frustrating for clinicians is that many patients have already taken the recommended steps: they follow medication regimens, adjust their diets, and modify other daily habits, yet their blood pressure continues to rise, and their blood sugar levels remain unregulated.

    The national statistics paint an alarming picture of the NCD crisis for the 120,000 residents of the so-called Spice Isle. Data from the 2012 Grenada Heart Project shows that 57.7% of the population is overweight or obese, 29.7% live with hypertension, and 13.3% have been diagnosed with diabetes. A 2022 progress monitoring report from the World Health Organization (WHO) adds more context: 83% of all deaths in Grenada are caused by NCDs, and 23% of people will die prematurely from one of these chronic conditions. The human and economic toll is devastating, with families reeling from the financial and emotional stress of caring for a loved one after a stroke, and many patients facing amputation due to complications from unmanaged diabetes.

    A recent joint review conducted by the World Bank and Grenada’s Ministry of Health, Wellness and Religious Affairs analyzed patient medical records across the country and confirmed what local clinicians have observed: at least 40% of patients undergoing treatment for hypertension or diabetes still do not have their conditions under control. The review identified several common barriers to effective management: gaps in patient health education, inconsistent clinical care standards, frequent medication shortages, and widespread preference for traditional herbal remedies over conventional medical treatment. However, the review failed to address one critical, understudied factor that may be driving poor outcomes: sleep health.

    No analysis was done of patients’ sleep quality, the prevalence of OSA, or the possibility that nocturnal sleep disturbances are quietly undermining all the clinical work done to manage chronic conditions during the day. OSA is a chronic physiological condition in which the upper airway partially or fully collapses repeatedly during sleep, setting off a chain of harmful biological responses. People living with untreated OSA experience persistent overnight elevated blood pressure, chronic systemic inflammation, and disruption of critical hormonal balances. Beyond these internal effects, OSA leaves patients waking up exhausted and unrefreshed, cutting into daily productivity and increasing the risk of car accidents due to drowsy driving. The single largest modifiable risk factor for OSA is obesity, meaning Grenada’s already widespread obesity epidemic is almost certainly driving a parallel, unrecognized growth in OSA rates across the country.

    Rigorous clinical research already supports the link between OSA and uncontrolled chronic disease. The Jackson Heart Sleep Study, a landmark investigation focused exclusively on African American participants, found that people with moderate to severe OSA were twice as likely to develop resistant hypertension — defined as blood pressure that remains above 130/80 mmHg even when a patient takes three or more different hypertension medications. This finding is particularly relevant to Grenada’s public health context, where 40% of treated hypertension patients still fail to hit their blood pressure targets. The study’s results raise a pressing clinical question: how many patients are being prescribed additional, unnecessary blood pressure medication when the root cause of their uncontrolled condition is actually undiagnosed OSA that requires sleep testing and targeted treatment?

    The racial and ancestral context of this crisis also cannot be ignored. The vast majority of Grenada’s population traces their ancestry to West Africa, and existing research confirms that people of African descent face a disproportionately high burden of OSA and its related cardiovascular complications. While most of this research has been conducted in the United States, the biological links hold across geographic boundaries. Early regional research in the Caribbean already supports this conclusion: a groundbreaking study conducted in Haiti found that nearly three-quarters of participants reported excessive daytime sleepiness, the most common hallmark symptom of OSA. These preliminary results make clear that more regional research is urgently needed to map the true prevalence of sleep disorders across Caribbean nations.

    OSA is a treatable condition, but it has been overlooked for decades, even as it contributes to the chronic disease burden that is overwhelming Grenada’s health system. Broadly speaking, healthy sleep is not an optional luxury — it is a foundational requirement for the body’s daily repair and restoration processes. A growing body of global research has confirmed the direct links between untreated OSA and hypertension, type 2 diabetes, and heart disease, making increased awareness among both clinicians and patients an urgent public health priority. For Grenada, as it works to turn the tide on its growing NCD crisis, one of the most impactful first steps toward better population health may turn out to be as simple, and as transformative, as helping more patients get a healthy night of sleep.

    This commentary was written by Dr. Kamilah Spencer, a board-certified Sleep Medicine and Internal Medicine physician who is developing a virtual medical practice to serve patients across the Caribbean.